104 related articles for article (PubMed ID: 18341036)
1. [Detection for subtype-specific genomic/genetic alterations in diffuse large B-cell lymphoma (DLBCL)].
Tagawa H
Rinsho Ketsueki; 2008 Feb; 49(2):73-81. PubMed ID: 18341036
[No Abstract] [Full Text] [Related]
2. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling analysis of the CD5+ diffuse large B-cell lymphoma subgroup: development of a CD5 signature.
Suguro M; Tagawa H; Kagami Y; Okamoto M; Ohshima K; Shiku H; Morishima Y; Nakamura S; Seto M
Cancer Sci; 2006 Sep; 97(9):868-74. PubMed ID: 16856881
[TBL] [Abstract][Full Text] [Related]
4. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
[TBL] [Abstract][Full Text] [Related]
5. Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization.
Karnan S; Tagawa H; Suzuki R; Suguro M; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
Genes Chromosomes Cancer; 2004 Jan; 39(1):77-81. PubMed ID: 14603444
[TBL] [Abstract][Full Text] [Related]
6. Gain of chromosome region 18q21 including the MALT1 gene is associated with the activated B-cell-like gene expression subtype and increased BCL2 gene dosage and protein expression in diffuse large B-cell lymphoma.
Dierlamm J; Murga Penas EM; Bentink S; Wessendorf S; Berger H; Hummel M; Klapper W; Lenze D; Rosenwald A; Haralambieva E; Ott G; Cogliatti SB; Möller P; Schwaenen C; Stein H; Löffler M; Spang R; Trümper L; Siebert R;
Haematologica; 2008 May; 93(5):688-96. PubMed ID: 18367485
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways.
Booman M; Szuhai K; Rosenwald A; Hartmann E; Kluin-Nelemans H; de Jong D; Schuuring E; Kluin P
J Pathol; 2008 Oct; 216(2):209-17. PubMed ID: 18729069
[TBL] [Abstract][Full Text] [Related]
8. [Gene expression profiling of de novo CD5-positive diffuse large B-cell lymphoma].
Kobayashi T; Kim S; Zhang W; Yamaguchi M; Ueno S; Morikawa J; Shiku H
Rinsho Ketsueki; 2003 Mar; 44(3):144-8. PubMed ID: 12722340
[No Abstract] [Full Text] [Related]
9. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.
Yamaguchi M; Nakamura N; Suzuki R; Kagami Y; Okamoto M; Ichinohasama R; Yoshino T; Suzumiya J; Murase T; Miura I; Ohshima K; Nishikori M; Tamaru J; Taniwaki M; Hirano M; Morishima Y; Ueda R; Shiku H; Nakamura S
Haematologica; 2008 Aug; 93(8):1195-202. PubMed ID: 18556402
[TBL] [Abstract][Full Text] [Related]
10. Secondary CD5+ diffuse large B-cell lymphoma not associated with transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (Richter syndrome).
Maeshima AM; Taniguchi H; Nomoto J; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Matsuno Y
Am J Clin Pathol; 2009 Mar; 131(3):339-46. PubMed ID: 19228640
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of diffuse large B-cell lymphoma.
Lossos IS
J Clin Oncol; 2005 Sep; 23(26):6351-7. PubMed ID: 16155019
[TBL] [Abstract][Full Text] [Related]
12. MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type.
Yoon SO; Jeon YK; Paik JH; Kim WY; Kim YA; Kim JE; Kim CW
Histopathology; 2008 Aug; 53(2):205-17. PubMed ID: 18752503
[TBL] [Abstract][Full Text] [Related]
13. Frequent occurrence of deletions in primary mediastinal B-cell lymphoma.
Kimm LR; deLeeuw RJ; Savage KJ; Rosenwald A; Campo E; Delabie J; Ott G; Muller-Hermelink HK; Jaffe ES; Rimsza LM; Weisenburger DD; Chan WC; Staudt LM; Connors JM; Gascoyne RD; Lam WL
Genes Chromosomes Cancer; 2007 Dec; 46(12):1090-7. PubMed ID: 17823928
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide array-based comparative genomic hybridization of diffuse large B-cell lymphoma: comparison between CD5-positive and CD5-negative cases.
Tagawa H; Tsuzuki S; Suzuki R; Karnan S; Ota A; Kameoka Y; Suguro M; Matsuo K; Yamaguchi M; Okamoto M; Morishima Y; Nakamura S; Seto M
Cancer Res; 2004 Sep; 64(17):5948-55. PubMed ID: 15342373
[TBL] [Abstract][Full Text] [Related]
15. Advancement in characterization of genomic alterations for improved diagnosis, treatment and prognostics in cancer.
Zhou X; Yu T; Cole SW; Wong DT
Expert Rev Mol Diagn; 2006 Jan; 6(1):39-50. PubMed ID: 16359266
[TBL] [Abstract][Full Text] [Related]
16. Molecular characteristics of diffuse large-B-cell lymphoma.
Magrath I
N Engl J Med; 2002 Jun; 346(25):1998-9. PubMed ID: 12075062
[No Abstract] [Full Text] [Related]
17. Mutations of the PIK3CA gene in diffuse large B cell lymphoma.
Baohua Y; Xiaoyan Z; Tiecheng Z; Tao Q; Daren S
Diagn Mol Pathol; 2008 Sep; 17(3):159-65. PubMed ID: 18382359
[TBL] [Abstract][Full Text] [Related]
18. Chromosome 11 genomic changes in parathyroid adenoma and hyperplasia: array CGH, FISH, and tissue microarrays.
Yi Y; Nowak NJ; Pacchia AL; Morrison C
Genes Chromosomes Cancer; 2008 Aug; 47(8):639-48. PubMed ID: 18398822
[TBL] [Abstract][Full Text] [Related]
19. Construction and analysis of tree models for chromosomal classification of diffuse large B-cell lymphomas.
Jiang HY; Huang ZX; Zhang XF; Desper R; Zhao T
World J Gastroenterol; 2007 Mar; 13(11):1737-42. PubMed ID: 17461480
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling in lymphoma diagnosis and management.
Iqbal J; Liu Z; Deffenbacher K; Chan WC
Best Pract Res Clin Haematol; 2009 Jun; 22(2):191-210. PubMed ID: 19698928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]